Guide for traveling through phosphoinositide pathway;Průvodce na cestu po fosfoinozitidové dráze

Psychiatrie

Volumn 11, Issue 1, 2007, Pages 8-12

  Strunecká, Anna ^a,c   Patočka, Jiří ^b  

^a Katedra Fyziologie ivo ich a Vývojové Biologie   (Czech Republic)

^b UNIVERSITY OF SOUTH BOHEMIA   (Czech Republic)

^c NONE   (Czech Republic)

Author keywords

Cell signaling; Inositol phosphates; Inositol phospholipids; Phosphoinositides; Second messenger

Indexed keywords

DIACYLGLYCEROL; INOSITOL 1,4,5 TRISPHOSPHATE; PHOSPHATIDYLINOSITIDE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; PHOSPHOLIPASE C;

ARTICLE; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; ENZYME ACTIVITY; MEMBRANE STRUCTURE; SIGNAL TRANSDUCTION;

EID: 34250898125     PISSN: 12117579     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Agranoff BW. Phosphorylated derivatives of myo-inositol. Fed Proc 1986;45:2629-2633.
2. Banerjee S, Hasan G. The InsP3 receptor: its role in neuronal physiology and neurodegeneration. Bioessays 2005;27:1035-1047.
3. Berridge MJ. A tale of two messengers. Nature 1993;365:388-389.
4. Berridge MJ. Unlocking the secrets of cell signaling. Annu Rev Physiol 2005;67:1-21.
5. Berridge MJ, Irvine RF. Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature 1984;312:315-321.
6. Berridge MJ, Downess CP, Hanley MR. Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands. Biochem J 1982;206:587-595.
7. Blazer-Yost BL, Nofziger C. Phosphoinositide lipid second messengers: new paradigms for transepithehal signal transduction. Pflugers Arch 2005;450:75-82.
8. Chesebro B, Trifilo M, Race R, Meade-White K, Teng C, LaCasse R, Raymond L, Favara C, Baron G, Priola S, Caughey B, Masliah E, Oldstone M. Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 2005; 308:1435-1446.
9. Folk P, Kmoníčková E, Krpejšová L, Strunecká A. 35S-labelled thiophosphorylated derivative of inositol trisphosphate. J of Labelled Compounds and Radiopharmaceuticals 1988;7:793-803.
10. Grases F, Simonet BM, Vucenik I, Perello J, Prieto RM, Shamsuddin AM. Effects of exogenous inositol hexakisphosphate (InsP(6)) on the levels of InsP(6) and of inositol trisphosphate (InsP(3)) in malignant cells, tissues and biological fluids. Life Sci 2002;71: 1535-1546.
11. Hokin LE, Hokin MR. The incorporation of 32P from triphosphate into polyphosphoinositides (gamma-32P)adenosine and phosphatide acid in erythrocyte membranes. Biochim Biophys Acta 1964;84:563-575.
12. Irvine RF. Inositide evolution - towards turtle domination? J Physiol 2005;566:295-300.
13. Irvine RF, Schell MJ. Back in the water: The return of the inositol phosphates. Nature Rev Mol Cell Biol 2001;2:327-338.
14. IUMBM: Numbering of atoms in myo-inositol. Biochem J 1989;258:1-2.
15. Majumder AL, Chatterjee A, Ghosh Dastidar K, Majee M. Diversification and evolution of L-myo-inositol 1-phosphate synthase.FEBS Lett 2003;553:3-10.
16. Michell RH, Perera NM, Dove SK. New insights into the roles of phosphoinositides and inositol polyphosphates in yeast. Biochem Soc Trans 2003;31:11-15.
17. Michell RH. Inositol phospholipids and cell surface receptor function. Biochim Biophys Acta 1975;415:81-147.
18. Rana RS, Hokin LE. Role of phosphoinositides in transmembrane signaling. Physiol Rev 1990;70:115-164.
19. Řípová D, Strunecká A, Platilová V, Hoschl C. Phosphoinositide signalling system in platelets of schizophrenic patients and the effect of neuroleptic therapy. Prostag Leucotr Ess 1999;61,125-129.
20. Shamir A, Shaltiel G, Greenberg ML, Belmaker RH, Agam G. The effect of lithium on expression of genes for inositol biosynthetic enzymes in mouse hippocampus; a comparison with the yeast model. Brain Res Mol Brain Res 2003;115:104-110.
21. Shears SB. How versatile are inositol phosphate kinases? Biochem J 2004;377:265-280.
22. Shepherd PR, Withers DJ, Siddle K. Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling. Biochem J 1998; 333: 471-490.
23. Streb H, Irvine RF, Berridge MJ, Schulz I. Release of Ca2+ from a non-mitochondrial intracellular store in pancreatic acinar cells by inositol-1,4,5-trisphosphate. Nature 1983;306:67-69.
24. Strunecká A. Vybrané kapitoly z biologie pro biochemiky a biofyziky. Skripta PřF UK Praha. SPN 1990;86
25. Strunecka A, el Desouki NI, Palecek J, Kmonickova E, Krpejsova L, Potter BV. The effect of inositol 1,4,5-trisphosphate and inositol 1,4,5- trisphosphorothioate on calcium release and membrane skeleton organization in the human red blood cell. Receptor 1991;1:141-154.
26. Strunecka A, Patocka J. Aluminofluoride complexes in the etiology of Alzheimer's disease. Structure and Bonding 2003;104:139-181.
27. Strunecká A., Patočka J., Šárek M. How does lithium mediate its therapeutic effects? J Appl Biomed 2005;3:25-35.
28. Strunecka A., Zborowski J. Microsomal synthesis of phosphatidylinositol and its exchange between subcellular structures of rat liver. Comp Biochem Physiol B. 1975;50:55-60.